Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-11-14FDA Approved: FLUTICASONE PROPIONATE HFA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate HFA submitted by Prasco Laboratories, confirming a regulatory change for …
-
FDA approval · 2014-11-13FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA, the combination inhaled therapy of fluticasone propionate and salmeterol xinafoa…
-
FDA approval · 2014-11-13FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate Diskus by Prasco Laboratories.
-
FDA approval · 2014-11-13FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) from GlaxoSmithKline LLC under NDA 021077.
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia [Phase 4]
A Phase 4 trial investigates whether dexmedetomidine modulates plasma inflammatory factors in asthma patients undergoing general anesthesia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-11-05Clinical Trial Update: Inhaler Technique Training [NA]
A clinical trial update about inhaler technique training for patients with asthma and chronic obstructive pulmonary disease, sponsored by No…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Control and Burden of Asthma and Rhinitis
The document reports the completion of a clinical trial conducted by Universidade do Porto on the control and burden of asthma and rhinitis.…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Better Asthma Outcomes: Lowering Tobacco Smoke Exposure [NA]
The update reports completion of a study examining the impact of reducing tobacco smoke exposure on asthma outcomes. No results are provided…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Impact of Lung Flute Therapy on Asthma
A completed clinical trial evaluating Lung Flute Therapy for persistent asthma has finished, sponsored by Medical Acoustics LLC.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics [Phase 1, Phase 2]
The document reports the completion of a Phase 1/2 pharmacokinetic study of Epinephrine Inhalation Aerosol USP delivered via an HFA-MDI for …
-
CLINICAL_TRIALS research · 2014-10-23Clinical Trial Update: Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3 [NA]
An update on a study aiming to develop and validate a sputum mRNA biomarker panel to aid in the diagnostic work-up of asthma; the trial stat…
-
FDA approval · 2014-10-21FDA Approved: TERBUTALINE SULFATE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for terbutaline sulfate from Fresenius Kabi USA, LLC, indicating an additional authorization related…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies [Phase 2]
A Phase 2 trial investigated the safety, pharmacodynamics, and effect on allergic reactivity of the Toll-like Receptor 7 agonist GSK2245035 …
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma [Phase 3]
A Phase 3 trial evaluating two doses of Tiotropium Respimat versus placebo in adolescents with severe persistent asthma reported efficacy an…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Health Effects of Early-Life Exposure to Urban Pollutants in Minority Children
A completed NIEHS-funded clinical trial evaluates how early-life exposure to urban pollutants affects health outcomes in minority children. …
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Exercise Training in Asthma Children [NA]
A completed clinical trial evaluating exercise training in children with asthma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: The Use of FKBP51 in the Identification of Non-adherence to Inhaled Corticosteroids in Difficult Asthma [NA]
Completed study evaluating FKBP51 as a biomarker to identify non-adherence to inhaled corticosteroids in difficult asthma.
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Dose-Response of Salmeterol in Children [Phase 4]
Phase 4 trial evaluating the dose-response of salmeterol in children with asthma; the study completed and results were posted in 2014.
-
CLINICAL_TRIALS withdrawal · 2014-10-07Clinical Trial Update: Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation
The clinical trial examining plasma miRNAs as potential biomarkers during asthma exacerbation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Efficacy and Safety of Navarixin (SCH 527123) in Participants With Allergen-Induced Asthma (P05363) [Phase 2]
Phase 2 clinical trial assessing efficacy and safety of Navarixin (SCH 527123) in participants with allergen-inducing asthma has completed w…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and Outcomes
This is a completed Phase II trial sponsored by GlaxoSmithKline evaluating inhaled corticosteroid/long-acting beta-agonist therapy during pr…
-
CLINICAL_TRIALS research · 2014-09-29Clinical Trial Update: Pathogenesis and Genetics of Environmental Asthma Ozone Study
NIEHS reports the completion of a clinical trial studying the pathogenesis and genetics of environmental asthma with ozone exposure.
-
FDA label_change · 2014-09-26FDA Approved: XOLAIR — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for XOLAIR (omalizumab) submitted by Genentech, resulting in a label change/indication update for th…
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma [Phase 2]
A Phase 2 trial evaluating the effects of BIIL 284 BS on induced sputum variables in patients with asthma has been completed.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: The DASH Diet for Adults With Uncontrolled Asthma [NA]
Clinical trial update on the DASH diet for adults with uncontrolled asthma, with hypertension as a co-condition. The trial status is complet…